• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Chugai

Red computer key with a warning symbol on it
Biotech

Chugai drops only AI-assisted antibody from pipeline

With the scrapping of phase 1 chronic disease candidate BRY10, Chugai now has no antibodies designed using its AI platform in clinical trials.
Darren Incorvaia Jan 30, 2026 10:55am
Chugai Matsunage plant circa 1943

JPM26: Chugai chases new science and name recognition

Jan 16, 2026 5:28am
Photo of an ax atop a pile of three logs

Roche axes 4 Chugai solid tumor assets in early-phase clear-out

Oct 23, 2025 4:53am
concept of computer chip and dollar sign

Chugai inks $250M deal for Gero’s age-related disease targets

Jul 7, 2025 3:00am
Close-up picture of Swiss cheese on cutting board

Roche's Chugai inks Swiss ADC deal potentially worth over $780M

Jan 8, 2025 8:00am
Biofourmis

Biofourmis, Chugai team up on measuring endometriosis pain

Jul 22, 2020 11:38am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings